| GC35974-100mg |
|
1354745-52-0 |
|
0 |
C24H17ClF3NO4 |
|
|
|
| GC35974-50mg |
|
1354745-52-0 |
|
0 |
C24H17ClF3NO4 |
|
|
|
| GC35974-10mg |
|
1354745-52-0 |
|
0 |
C24H17ClF3NO4 |
|
|
|
| GC35974-5mg |
|
1354745-52-0 |
|
0 |
C24H17ClF3NO4 |
|
|
|
| GC35974-10mM (in 1mL DMSO) |
|
1354745-52-0 |
|
0 |
C24H17ClF3NO4 |
|
|
|
| GC35973-100mg |
|
5081-48-1 |
Ellipticine hydrochloride
|
0 |
C17H15ClN2 |
|
|
|
| GC35973-50mg |
|
5081-48-1 |
Ellipticine hydrochloride
|
0 |
C17H15ClN2 |
|
|
|
| GC35973-10mg |
|
5081-48-1 |
Ellipticine hydrochloride
|
0 |
C17H15ClN2 |
|
|
|
| GC35973-5mg |
|
5081-48-1 |
Ellipticine hydrochloride
|
0 |
C17H15ClN2 |
|
|
|
| GC35973-10mM (in 1mL DMSO) |
|
5081-48-1 |
Ellipticine hydrochloride
|
0 |
C17H15ClN2 |
|
|
|
| GC35972-1mg |
|
— |
|
0 |
C30H44D6O5 |
|
|
|
| GC35971-1mg |
|
104121-92-8 |
|
0 |
C30H50O5 |
|
|
|
| GC35970-10mg |
|
1345839-28-2 |
|
0 |
C11H19Cl2N7O |
|
|
|
| GC35970-5mg |
|
1345839-28-2 |
|
0 |
C11H19Cl2N7O |
|
|
|
| GC35970-10mM (in 1mL DMSO) |
|
1345839-28-2 |
|
0 |
C11H19Cl2N7O |
|
|
|
| GC35966- |
|
2267329-76-8 |
|
0 |
— |
|
|
|
| GC35964-1mg |
|
869304-55-2 |
Eg5 Inhibitor V, trans-24
|
0 |
C26H21N3O3 |
|
|
|
| GC35963-50mg |
|
111011-76-8 |
Efonidipine hydrochloride monoethanolate
|
0 |
C36H45ClN3O8P |
|
|
|
| GC35963-10mg |
|
111011-76-8 |
Efonidipine hydrochloride monoethanolate
|
0 |
C36H45ClN3O8P |
|
|
|
| GC35963-10mM (in 1mL DMSO) |
|
111011-76-8 |
Efonidipine hydrochloride monoethanolate
|
0 |
C36H45ClN3O8P |
|
|
|
